Angelalign Technology (FRA:77D) Marketable Securities: €257.8 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:77D Angelalign Technology Inc FRA:77D
75 GF Score
Price €8.45
GF Value €11.61
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Angelalign Technology Marketable Securities?

Angelalign Technology FRA:77D -2.31% 75 Marketable Securities is €257.8 Mil as of Dec. 2025. GuruFocus rates FRA:77D with a GF Score™ of 75/100 and a GF Value™ of €11.61 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Angelalign Technology's Marketable Securities for the quarter that ended in Dec. 2025 was €257.8 Mil.

Angelalign Technology's annual Marketable Securities increased from Dec. 2023 (€97.1 Mil) to Dec. 2024 (€200.3 Mil) and increased from Dec. 2024 (€200.3 Mil) to Dec. 2025 (€257.8 Mil).

Angelalign Technology  (FRA:77D) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Angelalign Technology Marketable Securities Related Terms

Angelalign Technology Marketable Securities Historical Data

* Premium members only.

The historical data trend for Angelalign Technology's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angelalign Technology Marketable Securities Chart

Angelalign Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 97.11 200.29 257.85

Angelalign Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.11 321.18 200.29 315.65 257.85
FRA:77D
75GF Score
Angelalign Technology Inc FRA:77D
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Angelalign Technology Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €257.8 Mil mean?
Angelalign Technology (FRA:77D) has a Marketable Securities of €257.8 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Angelalign Technology and its competitors.
Is Angelalign Technology's Marketable Securities too high?
Angelalign Technology's current Marketable Securities is €257.8 Mil. Overall, Angelalign Technology has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Angelalign Technology's Marketable Securities compare to ISRG and BDX?
Angelalign Technology's Marketable Securities of €257.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Angelalign Technology and its competitors. Angelalign Technology's current Marketable Securities is €257.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angelalign Technology stock overvalued right now?
Based on GuruFocus' analysis, Angelalign Technology (FRA:77D) is currently considered Modestly Undervalued. The stock's GF Value™ is €11.61, compared to a current price of €8.45 — trading 27.2% below its estimated fair value. The current Marketable Securities is €257.8 Mil. Angelalign Technology's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Angelalign Technology (FRA:77D), the current Marketable Securities is €257.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Angelalign Technology (FRA:77D) Overvalued in 2026?

Based on GuruFocus' analysis, Angelalign Technology stock appears to be undervalued. The current stock price of €8.45 is trading 27.2% below its estimated GF Value™ of €11.61. GuruFocus considers Angelalign Technology to be Modestly Undervalued.

Key valuation signals for FRA:77D:

  • Marketable Securities: €257.8 Mil
  • GF Value™: €11.61 vs. price of €8.45 (27.2% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the FRA:77D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Angelalign Technology Business Description

Other Exchanges AGLFF:USA06699:Hong Kong
Address No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions, including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontic solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review, and modify treatment plans.
75GF Score

Get the complete analysis for FRA:77D

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.45
Price
€11.61
GF Value